Gained in Translation, Vancouver BC. September 29th 2012

Gained in Translation, Vancouver BC. September 29th 2012

Science

Gained in Translation, Vancouver BC. September 29th 2012

LIONS EYE SUMMIT: GAINED IN TRANSLATION. Simple format; each talk has two speakers, a clinician and a scientist. They talk about their work related to a specific eye disease.

  1. Russell Van Gelder, MD, PhD Welcome and Opening Remarks:
  2. #GainedinTranslation Clinicians and scientist share a mother tongue but dialects vary widely. Russell Van Gelder.
  3. Holly Chang, MD: Clinical challenges of ocular surface
    squamous neoplasia
    Val White, MD: HPV in
    ophthalmic neoplasia

  4. #GainedinTranslation. Wear your eye protection and the other too. Risk of eye surface carcinoma increases with UV exposure and HPV infection
  5. Kevin Gregory-Evans, MD, PhD: New pharmaceutical approaches in retinal
    therapeutics

    Jack Saari, PhD: Visual cycle modulation: An emerging concept in the treatment of
    retinal diseases

    Discussion

  6. #GainedinTranslation Inherited retina disease patient? Register at FFB Canada. A database to help fight blindness  http://www.ffb.ca 
  7. Keynote Address

    Don Zack, MD, PhD:

    Use of high content screening approaches to identify
    candidate neuroprotective molecules for the treatment of glaucoma and the
    retinal degenerations

  8. #GainedinTranslation Molecules that protect your eye’s nerves. Automatic screening and photoreceptor assays show DLK involved in glaucoma
  9. Greg Maloney, MD: Challenges of repeat corneal graft failure
    Tueng Shen, MD, PhD: Development of an artificial cornea for
    the developing world

  10. #GainedinTranslation Greg Maloney: 1.5 – 2 million people worldwide blind by corneal injury.
  11. #GainedinTranslation Can we reduce transplant rejection by replacing only parts of the cornea?
  12. #GainedinTranslation Artificial cornea with sensing chips and wireless signal for patient monitoring. Exiting perspective of the future!
  13. #GainedinTranslation: 90% of world’s blind in developing countries. 75% of those can be treated. Tueng Shen.
  14. Rob Schertzer, MD: Glaucoma: Not Just Pressure?
    Phil Horner, PhD: Mitochondrial fusion and metabolic
    vulnerability in early stage glaucoma

  15. #GainedinTranslation– Phil Horner in early stage glaucoma: NeuN marker shows that neurons are still present after axon transport is gone.
  16. David Maberley, MD, MSc: Diabetic retinopathy

    Ricky Wang, PhD: Ocular microcirculation imaging using
    optical coherence tomography

     

  17. Mark Slabaugh, MD: Understanding the optic nerve head
    structure in myopia and glaucoma

 

Paul Mackenzie, MD, PhD: Understanding the optic nerve head
structure in myopia and glaucoma